Drugs-Pharmaceutical Co. Ltd. Nanjing Branch - China

Nanjing Chinese Medicine (600713) to conduct a comprehensive inspection through the GSP, the implementation of science, industry and trade integration strategy, engaged in new drug development, production and marketing of a series of operations. Nanjing, a wholly-owned pharmaceutical research institutions - the life science and technology development center will have a strong ability to develop new drugs, new drugs have been developed four categories of two countries, two countries otherwise the new second-class